PL1638609T3 - Sposób wytwarzania kompleksów cząsteczkowych - Google Patents
Sposób wytwarzania kompleksów cząsteczkowychInfo
- Publication number
- PL1638609T3 PL1638609T3 PL04742568T PL04742568T PL1638609T3 PL 1638609 T3 PL1638609 T3 PL 1638609T3 PL 04742568 T PL04742568 T PL 04742568T PL 04742568 T PL04742568 T PL 04742568T PL 1638609 T3 PL1638609 T3 PL 1638609T3
- Authority
- PL
- Poland
- Prior art keywords
- molecular complexes
- preparation
- molecular
- recovered
- consist
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000009792 diffusion process Methods 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003068 static effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Extraction Or Liquid Replacement (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305140A FR2854079B1 (fr) | 2003-04-25 | 2003-04-25 | Procede de preparation de complexes moleculaires |
| EP04742568A EP1638609B1 (de) | 2003-04-25 | 2004-04-23 | Verfahren zur herstellung von molekularkomplexen |
| PCT/FR2004/000995 WO2004096284A1 (fr) | 2003-04-25 | 2004-04-23 | Procede de preparation de complexes moleculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1638609T3 true PL1638609T3 (pl) | 2012-09-28 |
Family
ID=33104420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04742568T PL1638609T3 (pl) | 2003-04-25 | 2004-04-23 | Sposób wytwarzania kompleksów cząsteczkowych |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8741346B2 (de) |
| EP (2) | EP2289561A1 (de) |
| JP (1) | JP5037936B2 (de) |
| KR (1) | KR101208256B1 (de) |
| CN (1) | CN100594941C (de) |
| AT (1) | ATE555811T1 (de) |
| AU (1) | AU2004233621B2 (de) |
| BR (1) | BRPI0409741B1 (de) |
| CA (1) | CA2523342C (de) |
| DK (1) | DK1638609T3 (de) |
| ES (1) | ES2386437T3 (de) |
| FR (1) | FR2854079B1 (de) |
| IL (1) | IL171520A (de) |
| MX (1) | MXPA05011505A (de) |
| NO (1) | NO335160B1 (de) |
| NZ (1) | NZ543209A (de) |
| PL (1) | PL1638609T3 (de) |
| PT (1) | PT1638609E (de) |
| RU (2) | RU2353392C2 (de) |
| SI (1) | SI1638609T1 (de) |
| WO (1) | WO2004096284A1 (de) |
| ZA (1) | ZA200508469B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2382654C2 (ru) * | 2004-04-01 | 2010-02-27 | Пьер Фабр Медикаман | Комплексы включения, полученные способом с использованием co2 в сверхкритическом состоянии и агента взаимодействия с комплексом |
| FR2876911B1 (fr) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine |
| FR2876910B1 (fr) | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction |
| FR2876914A1 (fr) * | 2004-10-21 | 2006-04-28 | Pierre Fabre Medicament Sa | Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction |
| FR2944278B1 (fr) * | 2009-04-09 | 2011-11-18 | Pf Medicament | Procede de preparation de complexes moleculaires entre un agent retinoide et des cyclodextrines |
| FR2944280B1 (fr) * | 2009-04-09 | 2012-08-03 | Galderma Res & Dev | Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines |
| FR2944207B1 (fr) * | 2009-04-09 | 2011-05-06 | Galderma Res & Dev | Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations |
| JP5622187B2 (ja) * | 2009-09-08 | 2014-11-12 | 群泰生物科技股▲ふん▼有限公司 | 水溶性ミノキシジル組成物 |
| US10328152B2 (en) | 2011-06-16 | 2019-06-25 | Nayan Patel | Method for stabilization and delivery of therapeutic molecules |
| GB201609222D0 (en) | 2016-05-25 | 2016-07-06 | F2G Ltd | Pharmaceutical formulation |
| US10532102B2 (en) | 2016-08-19 | 2020-01-14 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical composition and methods of uses |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
| AU2020370166B2 (en) * | 2019-10-21 | 2022-05-19 | Esolate Ltd | Superfine compounds and production thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2191715B (en) | 1986-06-17 | 1990-07-25 | Midrex Int Bv | Method and apparatus for dedusting and desulfurizing gases |
| JPH0677511B2 (ja) | 1986-12-05 | 1994-10-05 | 金印わさび株式会社 | 香辛成分の包接化合物の製造方法 |
| US4822497A (en) | 1987-09-22 | 1989-04-18 | Modar, Inc. | Method for solids separation in a wet oxidation type process |
| DE3744329A1 (de) | 1987-12-28 | 1989-07-06 | Schwarz Pharma Gmbh | Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung |
| FR2629735B1 (fr) | 1988-04-11 | 1991-03-22 | Agronomique Inst Nat Rech | Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus |
| RU2108109C1 (ru) * | 1990-10-04 | 1998-04-10 | Мадаус АГ | Способ получения комплекса силибинина с циклодекстрином, комплекс включения силибинина с циклодекстрином, фармацевтическая композиция антигепатотоксической активности и способ ее получения |
| GB9100643D0 (en) | 1991-01-11 | 1991-02-27 | Shaffery Michael J | Filter system |
| JP3043085B2 (ja) * | 1991-03-18 | 2000-05-22 | 日本たばこ産業株式会社 | 包接化合物の製造方法 |
| US5389263A (en) | 1992-05-20 | 1995-02-14 | Phasex Corporation | Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX |
| EP0687174B1 (de) * | 1993-03-05 | 2001-06-13 | Hexal Ag | Kristallinische cyclodextrin-einschlusskomplexe von ranitidinhxdrochlorid und verfahren |
| ATE166573T1 (de) | 1993-03-24 | 1998-06-15 | Ciba Geigy Ag | Verfahren zur herstellung einer liposomendispersion im hochdruckbereich |
| GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| EP0706821A1 (de) | 1994-10-06 | 1996-04-17 | Centre De Microencapsulation | Verfahren zum Beschichten von Partikeln |
| FR2725990B1 (fr) | 1994-10-21 | 1997-01-10 | Pf Medicament | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux |
| FR2741619B1 (fr) | 1995-11-28 | 1998-02-13 | Pf Medicament | Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique |
| JP3986086B2 (ja) | 1996-03-01 | 2007-10-03 | ザ ユニバーシティ オブ カンザス | 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法 |
| FR2753639B1 (fr) | 1996-09-25 | 1998-12-11 | Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede | |
| US5766637A (en) | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
| DE19711393C1 (de) | 1997-03-19 | 1998-08-13 | Fraunhofer Ges Forschung | Verfahren zum Mikroverkapseln von Partikeln |
| GB9800936D0 (en) | 1997-05-10 | 1998-03-11 | Univ Nottingham | Biofunctional polymers |
| IT1296464B1 (it) | 1997-11-19 | 1999-06-25 | Vectorpharma Int | Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante |
| GB9810559D0 (en) | 1998-05-15 | 1998-07-15 | Bradford Particle Design Ltd | Method and apparatus for particle formation |
| GB9824298D0 (en) | 1998-11-05 | 1998-12-30 | Smithkline Beecham Plc | Novel process |
| FR2798863B1 (fr) | 1999-09-27 | 2001-12-28 | Separex Sa | Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit |
| FR2799984B1 (fr) | 1999-10-21 | 2002-05-03 | Lavipharm | Procede de fractionnement d'une matiere composee de plusieurs constituants a l'aide d'un solvant a pression supercritique |
| FR2803538B1 (fr) | 1999-12-15 | 2002-06-07 | Separex Sa | Procede et dispositif de captage de fines particules par percolation dans un lit de granules |
| FR2815540B1 (fr) * | 2000-10-19 | 2005-06-10 | Separex Sa | Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote |
| WO2002089851A1 (fr) | 2001-03-06 | 2002-11-14 | Separex (Societe Anonyme) | Procede de fabrication de complexes hote-client |
| FR2823207B1 (fr) * | 2001-04-10 | 2004-12-03 | Pf Medicament | Complexes d'anilides a chaine polycarbonee et de cyclodestrines, leur preparation et leur application en tant que medicamment en particulier pour le traitement des dislipidemies |
| FR2830760B1 (fr) * | 2001-10-12 | 2004-06-04 | Pf Medicament | Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique |
| FR2830761B1 (fr) * | 2001-10-12 | 2003-12-12 | Pf Medicament | Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique |
-
2003
- 2003-04-25 FR FR0305140A patent/FR2854079B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-23 PL PL04742568T patent/PL1638609T3/pl unknown
- 2004-04-23 WO PCT/FR2004/000995 patent/WO2004096284A1/fr not_active Ceased
- 2004-04-23 MX MXPA05011505A patent/MXPA05011505A/es active IP Right Grant
- 2004-04-23 ES ES04742568T patent/ES2386437T3/es not_active Expired - Lifetime
- 2004-04-23 PT PT04742568T patent/PT1638609E/pt unknown
- 2004-04-23 BR BRPI0409741A patent/BRPI0409741B1/pt not_active IP Right Cessation
- 2004-04-23 SI SI200431896T patent/SI1638609T1/sl unknown
- 2004-04-23 EP EP10179575A patent/EP2289561A1/de not_active Withdrawn
- 2004-04-23 US US10/554,058 patent/US8741346B2/en not_active Expired - Fee Related
- 2004-04-23 RU RU2005136664/15A patent/RU2353392C2/ru not_active IP Right Cessation
- 2004-04-23 NZ NZ543209A patent/NZ543209A/en not_active IP Right Cessation
- 2004-04-23 AU AU2004233621A patent/AU2004233621B2/en not_active Ceased
- 2004-04-23 AT AT04742568T patent/ATE555811T1/de active
- 2004-04-23 EP EP04742568A patent/EP1638609B1/de not_active Expired - Lifetime
- 2004-04-23 DK DK04742568.1T patent/DK1638609T3/da active
- 2004-04-23 JP JP2006505810A patent/JP5037936B2/ja not_active Expired - Fee Related
- 2004-04-23 CA CA2523342A patent/CA2523342C/fr not_active Expired - Fee Related
- 2004-04-23 CN CN200480014408A patent/CN100594941C/zh not_active Expired - Fee Related
-
2005
- 2005-10-19 ZA ZA200508469A patent/ZA200508469B/en unknown
- 2005-10-20 IL IL171520A patent/IL171520A/en active IP Right Grant
- 2005-10-25 KR KR1020057020310A patent/KR101208256B1/ko not_active Expired - Fee Related
- 2005-11-18 NO NO20055467A patent/NO335160B1/no not_active IP Right Cessation
-
2008
- 2008-09-15 RU RU2008137041/15A patent/RU2008137041A/ru not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1638609T1 (sl) | Postopek za pripravo molekulskih kompleksov | |
| NZ520671A (en) | Foaming agents for use in coal seam reservoirs | |
| GB2442374A (en) | Crosslinkable polymer compositions | |
| AU2001257305A1 (en) | Hematology blood control and method for preparation of same | |
| NO20054089D0 (no) | Ultralydkontrastmidler og fremgangsmate for fremstilling derav | |
| CA2517063A1 (en) | A method of using a swelling agent to prevent a cement slurry from being lost to a subterranean formation | |
| AU2003252985A1 (en) | Process for treating a formation | |
| AU2002212412A1 (en) | Method for making very fine particles consisting of a principle inserted in a host molecule | |
| NO20075525L (no) | Fremgangsmate og vaeske for syrebehandling av underjordiske formasjoner | |
| ATE432063T1 (de) | Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft | |
| DE69920945D1 (de) | Verfahren zur herstellung von arzneistoffpartikeln | |
| NO20055641L (no) | Fremgangsmate for a behandle en underjordisk formasjon og vannbasert behandlingsvaeske til bruk ved utforelsen av fremgangsmaten | |
| AU2016204275A1 (en) | Method and system for treating a subterranean formation | |
| ATE546130T1 (de) | Dispersion von polymerteilchen | |
| AR032016A1 (es) | Una composicion catalizadora y los metodos para su preparacion y el uso en un proceso de polimerizacion | |
| ATE348630T1 (de) | Verminderung der nebenwirkungen der chemotherapie in krebspatienten | |
| BR0213220A (pt) | Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso | |
| WO2005097201A3 (fr) | Complexes d’inclusions comprenant du piroxicam, une cyclodextrine et l’arginine | |
| WO2005098449A3 (en) | Hausp-mdm2 interaction and uses thereof | |
| BR0112258A (pt) | Sistema de entrega de droga para drogas pouco solúveis em água | |
| CA2388325A1 (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| SE0400523D0 (sv) | A medical solution, a method for producing said medical solution and use thereof | |
| ATE337073T1 (de) | Verfahren zur hochdruck-gastrennung | |
| TW200632141A (en) | Method and system for injecting chemistry into a supercritical fluid | |
| AU7269100A (en) | Method for indirectly determining the blood-clotting status |